A Vyepti infusion typically takes about 30 minutes to complete the delivery of the medication. Patients should plan for a longer total visit to account for necessary clinical steps, including check-in, vitals assessment, and IV placement. After the infusion concludes, clinical staff perform a brief monitoring period to ensure you feel well before leaving. You can ask for a specific time estimate when booking at your preferred infusion center location.

Preventive benefits from this therapy are typically observed and tracked over several weeks, though some patients report improvements shortly after their first session. Because individual responses vary, we recommend maintaining a detailed headache diary to record the frequency and severity of your migraines. 

Tracking your use of rescue medications and identifying potential triggers provides your neurologist with the data needed to evaluate the treatment’s effectiveness during your quarterly follow-up appointments.

The primary difference between these options is the administration method and frequency. Vyepti is a clinician-administered IV therapy given every 12 weeks, while other CGRP inhibitors are often self-injected monthly. 

Some patients choose the infusion model because it provides professional supervision and a consistent quarterly schedule, which removes the responsibility of self-administration and tracking at home. This approach ensures clinical oversight during every dose.

The most common side effects reported are mild, cold-like symptoms such as a sore throat or nasal congestion. It is important to inform your nurse immediately if you experience any signs of a hypersensitivity reaction during the 30-minute administration, such as itching, rash, or shortness of breath. 

Our clinical teams monitor every patient throughout the session to manage these risks, but you should seek emergency care if you develop severe allergic symptoms after leaving the facility.

While this therapy is safe for many adults, it is not appropriate for individuals with Hereditary Fructose Intolerance (HFI) because the formulation contains sorbitol. Patients must disclose this rare condition, along with any history of medication allergies or their current pregnancy and breastfeeding status, during the initial screening process. 

Sharing a complete list of your current prescriptions helps our clinicians ensure that the treatment is integrated safely into your broader migraine management plan.

Coverage for specialty infusions varies based on your specific insurance provider and plan. TwelveStone Health Partners conducts a thorough benefits verification and assists with necessary prior authorizations to determine your out of pocket responsibility before you start. You can begin the enrollment process by having your provider submit a referral or by visiting our contact page to speak with a care coordinator.

TwelveStone Health provides Vyepti® Infusion Treatment as a preventive IV therapy for adults living with chronic or frequent migraines. This treatment is administered once every 12 weeks to help reduce migraine frequency and support long-term symptom control.

The medication is delivered through a 30-minute IV infusion. Your visit also includes check-in, clinical monitoring, and support from our specialized nursing team. We coordinate with your provider and manage insurance authorizations to simplify the treatment process.

Contact TwelveStone Health today to schedule your infusion or coordinate a referral.

Trusted Regional Infusion Care

  • 30+ Regional Centers: Serving Tennessee, Kentucky, Georgia, Mississippi, and Virginia.
  • 35-Year Heritage: Proven history of clinical excellence and compassionate patient care.
  • PharmD-Led Clinical Team: Registered nurses supervised by clinical pharmacists and senior leadership.
  • Insurance Coordination: Full benefits verification and prior authorization support for major plans.
  • Private Patient Suites: Individual rooms featuring WiFi, refreshments, and dedicated recliners.

Understanding Vyepti and the CGRP Pathway

Vyepti® (eptinezumab-jjmr) is an FDA-approved preventive treatment for migraines in adults. It works by targeting the CGRP pathway, a key protein involved in migraine pain signaling. By blocking this pathway, Vyepti helps reduce the frequency and severity of migraine attacks.

Dosing and Patient Profile

Clinicians typically schedule infusions every 12 weeks. Your prescribing provider will determine a dose of either 100 mg or 300 mg based on your clinical needs. This quarterly cadence ensures consistent medication levels without the requirement for daily pills or monthly self-injections.

Neurologists often consider this therapy for patients with a high chronic migraine burden or those who have seen insufficient results from other preventives. TwelveStone Health Partners coordinates directly with your physician for medical orders and ongoing communication. To discuss your Vyepti® Infusion Treatment options, schedule your appointment.

What to Expect During Your Infusion Appointment

Your Vyepti® Infusion Treatment begins with a streamlined check-in process at a TwelveStone infusion center. A nurse then guides you to a private infusion suite designed to provide a calm, personal environment. These spaces prioritize your comfort during the procedure and include several amenities:

  • Individual leather recliners
  • High-speed WiFi and televisions
  • Complimentary snacks and beverages
  • Climate-controlled private rooms

Once you are settled, a registered nurse checks your vitals and prepares the IV site. The medication typically infuses over 30 minutes. You should plan for a longer total visit time to account for clinical preparation and a brief post-infusion monitoring period in a controlled setting.

Staff remains available throughout the session for clinical questions or support. Because TwelveStone is a faith-based organization, optional chaplain support is available for patients who request spiritual encouragement. After monitoring is complete, our care coordinators help schedule your next quarterly appointment to ensure your preventive therapy remains consistent and on schedule.

Safety Standards and Clinical Monitoring

All medical infusions involve the potential for side effects. We prioritize patient safety through active clinical monitoring throughout every Vyepti® Infusion Treatment session. 

Common reactions include cold-like symptoms such as nasal or throat congestion. While these are usually mild, our registered nurses are prepared to respond immediately to any signs of hypersensitivity.

Pre-Treatment Screening

Safety begins with a thorough screening of your medical history before your first appointment. Please disclose specific health factors to our clinical team, including:

  • Hereditary Fructose Intolerance (HFI) due to sorbitol content
  • Pregnancy or breastfeeding status
  • Known medication allergies
  • Current prescription medications

This information helps our clinical staff ensure the therapy is appropriate for your specific health profile. We recommend discussing your full history with your neurologist and the TwelveStone team to determine eligibility rather than self-screening. To begin the coordination process at one of our regional infusion centers, visit our contact page.

Insurance, Costs, and Starting Your Treatment

Specialty infusion pricing depends on your insurance plan. The most practical first step toward Vyepti® Infusion Treatment is a comprehensive benefits verification. TwelveStone Health Partners provides support for insurance review, prior authorization, and financial counseling. These services clarify expected costs and identify assistance options before your first appointment. Many patients with commercial insurance qualify for manufacturer copay support to reduce expenses.

We manage the transition from your provider through a standardized sequence:

  1. Prescriber order or medical referral submission
  2. Insurance review and financial consultation
  3. Scheduling at a regional infusion center
  4. Ongoing coordination for 12-week appointments

TwelveStone operates 30+ locations across Tennessee, Kentucky, Georgia, Mississippi, and Virginia. Home infusion may also be an option when clinically appropriate. View our chronic conditions hub or migraine page for more information.

To request scheduling or coordinate a referral, visit our contact page to speak with a care coordinator. Our staff manages the administrative process to ensure clinical continuity.

Frequently Asked Questions About Vyepti Infusions

A Vyepti infusion typically takes about 30 minutes to complete the delivery of the medication. Patients should plan for a longer total visit to account for necessary clinical steps, including check-in, vitals assessment, and IV placement. After the infusion concludes, clinical staff perform a brief monitoring period to ensure you feel well before leaving. You can ask for a specific time estimate when booking at your preferred infusion center location.

Preventive benefits from this therapy are typically observed and tracked over several weeks, though some patients report improvements shortly after their first session. Because individual responses vary, we recommend maintaining a detailed headache diary to record the frequency and severity of your migraines. 

Tracking your use of rescue medications and identifying potential triggers provides your neurologist with the data needed to evaluate the treatment’s effectiveness during your quarterly follow-up appointments.

The primary difference between these options is the administration method and frequency. Vyepti is a clinician-administered IV therapy given every 12 weeks, while other CGRP inhibitors are often self-injected monthly. 

Some patients choose the infusion model because it provides professional supervision and a consistent quarterly schedule, which removes the responsibility of self-administration and tracking at home. This approach ensures clinical oversight during every dose.

The most common side effects reported are mild, cold-like symptoms such as a sore throat or nasal congestion. It is important to inform your nurse immediately if you experience any signs of a hypersensitivity reaction during the 30-minute administration, such as itching, rash, or shortness of breath. 

Our clinical teams monitor every patient throughout the session to manage these risks, but you should seek emergency care if you develop severe allergic symptoms after leaving the facility.

While this therapy is safe for many adults, it is not appropriate for individuals with Hereditary Fructose Intolerance (HFI) because the formulation contains sorbitol. Patients must disclose this rare condition, along with any history of medication allergies or their current pregnancy and breastfeeding status, during the initial screening process. 

Sharing a complete list of your current prescriptions helps our clinicians ensure that the treatment is integrated safely into your broader migraine management plan.

Coverage for specialty infusions varies based on your specific insurance provider and plan. TwelveStone Health Partners conducts a thorough benefits verification and assists with necessary prior authorizations to determine your out of pocket responsibility before you start. You can begin the enrollment process by having your provider submit a referral or by visiting our contact page to speak with a care coordinator.